EUVIMEDEUVIMED entdecken
Open Access

Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study

Sungho Bea, Elisabetta Patorno, Georg Hahn, Julie M Paik, Deborah J Wexler, Katsiaryna Bykov

Drug Safety · 2025

DOI: 10.1007/s40264-025-01629-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, 2025. Verfasst von Sungho Bea und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, …. Hauptthemen laut MEDLINE: Sulfonylurea Compounds, Hypoglycemia, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, American Diabetes Association, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sulfonylureas (SU) are widely used for diabetes management in older adults but can cause hypoglycemia, which may be worsened by drug interactions. We applied high-throughput data mining to identify medications that could increase hypoglycemia risk when taken with SU. METHODS: Using Medicare, MarketScan, and Optum Clinformatics (2003-2022), we identified patients aged ≥ 65 years who experienced a severe hypoglycemic event after at least 90 days on SU. We evaluated all medications dispensed in the 90 days before the event using a case-crossover (CCO) design. We adjusted for time-varying confounding and direct effect of the evaluated medications (precipitant) using a case-case time-control (CCTC) approach and metformin as control. We computed odds ratios (ORs) for its association with hypoglycemia. The false discovery rate (FDR) was controlled at 0.05 to adjust for multiple testing. To reduce confounding from other diabetes medications, we analyzed non-diabetes and diabetes medications separately. RESULTS: Among 1607 candidate drugs received before experiencing hypoglycemia, 86 non-diabetes medications showed a CCO OR ≥ 1.00. With metformin as control, sulfamethoxazole/trimethoprim (CCTC OR 1.76, p < 0.01, FDR q < 0.01) and metronidazole (CCTC OR 2.17, p < 0.01, FDR q = 0.04) were associated with severe hypoglycemia. Among 10 diabetes medications, insulin showed increased association (CCO OR 1.22, p < 0.01); however, once adjusted for the drug's direct effects, CCTC OR was 1.03 (p = 0.47, FDR q = 0.47). CONCLUSIONS: Using a high-throughput data mining approach, we identified two antibiotics (sulfamethoxazole/trimethoprim and metronidazole) that may increase hypoglycemia risk in older adults on sulfonylureas. Given the exploratory nature of this study, these findings warrant further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sulfonylurea CompoundsHypoglycemiaHypoglycemic AgentsHumansAgedCross-Over StudiesFemaleMaleAged, 80 and overDrug InteractionsCase-Control StudiesHigh-Throughput Screening AssaysMetforminUnited StatesData Mining

Substanzen

Sulfonylurea CompoundsHypoglycemic AgentsMetformin

Autor:innen und Institutionen

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA, USA.
  • Department of Medicine, Division of Endocrinology, Massachusetts General Hospital Diabetes Center, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. kbykov@bwh.harvard.edu.

Förderung

  • NIA NIH HHS
  • American Diabetes Association
  • National Institute of Health

Zitieren

APA

Bea, S., Patorno, E., Hahn, G., Paik, J. M., Wexler, D. J., & Bykov, K. (2025). Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study. Drug Safety. https://doi.org/10.1007/s40264-025-01629-3

Vancouver

Bea S, Patorno E, Hahn G, Paik JM, Wexler DJ, Bykov K. Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study. Drug Safety. 2025. doi:10.1007/s40264-025-01629-3

BibTeX
@article{Bea2025,
  author = {Bea, Sungho and Patorno, Elisabetta and Hahn, Georg and Paik, Julie M and Wexler, Deborah J and Bykov, Katsiaryna},
  title = {Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study},
  journal = {Drug Safety},
  year = {2025},
  doi = {10.1007/s40264-025-01629-3}
}
Kostenlos starten →